Business Description
Dimerix Ltd
ISIN : AU000000DXB7
Description
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 147.61 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -20.5 | |||||
| 3-Year EPS without NRI Growth Rate | -17.3 | |||||
| 3-Year FCF Growth Rate | -13 | |||||
| 3-Year Book Growth Rate | -27.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.84 | |||||
| 9-Day RSI | 28.65 | |||||
| 14-Day RSI | 34.49 | |||||
| 6-1 Month Momentum % | -33.65 | |||||
| 12-1 Month Momentum % | 91.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.49 | |||||
| Quick Ratio | 9.49 | |||||
| Cash Ratio | 6.58 | |||||
| Days Sales Outstanding | 1089.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.5 | |||||
| Shareholder Yield % | -15.9 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -19281.2 | |||||
| Net Margin % | -12838.35 | |||||
| FCF Margin % | -5278.2 | |||||
| ROE % | -198.04 | |||||
| ROA % | -78.9 | |||||
| ROIC % | -491.8 | |||||
| ROC (Joel Greenblatt) % | -43220.22 | |||||
| ROCE % | -164.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 5.34 | |||||
| PB Ratio | 9.4 | |||||
| Price-to-Tangible-Book | 10.33 | |||||
| EV-to-EBIT | -5.89 | |||||
| EV-to-EBITDA | -5.89 | |||||
| EV-to-Revenue | 1134.94 | |||||
| EV-to-Forward-Revenue | 4.82 | |||||
| EV-to-FCF | -21.9 | |||||
| Price-to-Net-Current-Asset-Value | 10.33 | |||||
| Price-to-Net-Cash | 31 | |||||
| Earnings Yield (Greenblatt) % | -16.98 | |||||
| FCF Yield % | -4.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dimerix Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.133 | ||
| EPS (TTM) (A$) | -0.038 | ||
| Beta | -0.54 | ||
| Volatility % | 78.44 | ||
| 14-Day RSI | 34.49 | ||
| 14-Day ATR (A$) | 0.018581 | ||
| 20-Day SMA (A$) | 0.345 | ||
| 12-1 Month Momentum % | 91.67 | ||
| 52-Week Range (A$) | 0.16 - 0.665 | ||
| Shares Outstanding (Mil) | 557.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dimerix Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dimerix Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dimerix Ltd Frequently Asked Questions
What is Dimerix Ltd(ASX:DXB)'s stock price today?
The current price of ASX:DXB is A$0.31. The 52 week high of ASX:DXB is A$0.67 and 52 week low is A$0.16.
When is next earnings date of Dimerix Ltd(ASX:DXB)?
The next earnings date of Dimerix Ltd(ASX:DXB) is .
Does Dimerix Ltd(ASX:DXB) pay dividends? If so, how much?
Dimerix Ltd(ASX:DXB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers